PubRank

Maria Del Zompo

Author PubWeight™ 31.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study. Schizophr Res 2005 2.12
2 The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis 2010 1.19
3 Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics 2010 1.09
4 Duration of lithium treatment is a risk factor for reduced glomerular function: a cross-sectional study. BMC Med 2013 1.01
5 Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. Neurobiol Aging 2011 1.00
6 The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 2010 0.98
7 Migraine and tumour necrosis factor gene polymorphism. An association study in a Sardinian sample. J Neurol 2009 0.97
8 Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder. Pharmacogenomics 2011 0.96
9 Age at onset in Sardinian bipolar I patients: evidence for three subgroups. Bipolar Disord 2008 0.94
10 Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. Neurosci Lett 2009 0.94
11 Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment. Neuropsychobiology 2005 0.93
12 Admixture analysis of age at onset in bipolar disorder. Psychiatry Res 2010 0.87
13 Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res 2013 0.86
14 A48G polymorphism in the D1 receptor genes associated with bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet 2005 0.86
15 Pharmacogenomics of bipolar disorder. Pharmacogenomics 2013 0.85
16 Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. Am J Med Genet B Neuropsychiatr Genet 2007 0.85
17 Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord 2009 0.85
18 Renal function during long-term lithium treatment: a cross-sectional and longitudinal study. BMC Med 2015 0.83
19 Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disord 2012 0.82
20 Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients. J Mol Neurosci 2015 0.81
21 Long-term lithium treatment and survival from external causes including suicide. J Clin Psychopharmacol 2007 0.81
22 A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample. Psychiatr Genet 2008 0.80
23 Differential effect of lithium on spermidine/spermine N1-acetyltransferase expression in suicidal behaviour. Int J Neuropsychopharmacol 2013 0.80
24 Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 2007 0.79
25 NRG1 and BDNF genes in schizophrenia: an association study in an Italian case-control sample. Psychiatry Res 2010 0.79
26 Adverse drug reactions: role of pharmacogenomics. Pharmacol Res 2004 0.79
27 No association between lithium full responders and the DRD1, DRD2, DRD3, DAT1, 5-HTTLPR and HTR2A genes in a Sardinian sample. Psychiatry Res 2009 0.79
28 [Evaluation of lithium treatment response in Sardinian bipolar patients]. Riv Psichiatr 2010 0.77
29 Continuation versus discontinuation of lithium during pregnancy: a retrospective case series. J Clin Psychopharmacol 2014 0.77
30 Preliminary Transcriptome Analysis in Lymphoblasts from Cluster Headache and Bipolar Disorder Patients Implicates Dysregulation of Circadian and Serotonergic Genes. J Mol Neurosci 2015 0.77
31 Adverse reactions during imatinib and lansoprazole treatment in gastrointestinal stromal tumors. Ann Pharmacother 2004 0.77
32 C9ORF72 repeat expansion and bipolar disorder - is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder. Bipolar Disord 2014 0.77
33 Association study between the phenotype migraine without aura-panic disorder and dopaminergic receptor genes. Pharmacol Res 2003 0.77
34 Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia. Eur Neuropsychopharmacol 2012 0.76
35 Manic-depressive illness: an association study with the inositol polyphosphate 1-phosphatase and serotonin transporter genes. Psychiatr Genet 2002 0.75
36 Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder. Hum Genomics Proteomics 2010 0.75
37 Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One 2017 0.75
38 A retrospective case series of bipolar patients with adjunctive carbamazepine in long-term lithium treatment: evaluation of the effectiveness. J Clin Psychopharmacol 2011 0.75
39 No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample. Psychiatry Res 2013 0.75
40 Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees. Bipolar Disord 2013 0.75
41 Evaluation of lithium response in episodic cluster headache: a retrospective case series. Headache 2012 0.75